The National Lipid Association has released an updated expert clinical consensus on the identification, diagnosis, and management of familial hypercholesterolemia (FH) available open access in the Journal of Clinical Lipidology. This updated expert consensus highlights advances in diagnosis, genetics, and treatment for this lifelong condition that requires lifelong attention.
Key updates in the new NLA guidance include:
The National Lipid Association (NLA) today announced the release of a major new clinical guidance document titled “LDL Cholesterol Management Simplified in Adults – Lower for Longer is Better: Guidance from the National Lipid Association,” now available open access in the Journal of Clinical Lipidology. This expert consensus underscores a vital message for clinicians and patients alike: lowering LDL-C early, intensively, and sustainably is critical to reducing the risk of cardiovascular events.
The National Lipid Association (NLA) has released a comprehensive clinical review titled “Familial Chylomicronemia Syndrome: An Expert Clinical Review from the National Lipid Association.” This new guidance provides an in-depth examination of the diagnosis, management, and treatment landscape for familial chylomicronemia syndrome (FCS) — a rare and severe genetic disorder characterized by extremely high triglyceride levels (≥ 1,000 mg/dL) and an elevated risk of life-threatening recurrent acute pancreatitis.
.jpg)
.png)
